In 1958, Ludwig Merckle GmbH in Vienna was founded as the first foreign branch of the German Merckle Arzneimittel GmbH. This was renamed ratiopharm Arzneimittel Vertriebs-GmbH 40 years later. In the years that followed, the company specialised in the marketing and sales of generic medication – copies of original pharmaceuticals already available made with identical active substances – as well as over-the-counter medicinal products (OTC medicines). Biotechnologically produced medicines (biologicals) for the supportive therapy of cancer patients have also been in the range since 2009. The ratiopharm Group was taken over by TEVA Pharmaceutical Industries in 2010.
The TEVA corporation, which specialises in the development, production and sale of generics and innovative medications, the latter for the central nervous system, oncology, pain therapy and gynaecology, is one of the 15 largest pharmaceutical companies in the world and is the market leader in the medicinal treatment of multiple sclerosis. Since the acquisition of the Cephalon Group in 2011, TEVA-ratiopharm in Austria has been offering generic brands and popular OTC products such as ratioDolor®, as well as a wide range of original products, making it one of the leading pharmaceutical conglomerates in Austria.
Year of establishment1958
Development and sale of generic
medicinal products, biologicals,
OTC products and innovative
original products; over 150 products;
around 15.4 million packages sold annually